Posted by Michael Wonder on 12 Nov 2019
EMA publishes agenda for 11-14 November CHMP meeting
11 November 2019 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Deferasirox
- Osilodrostat phosphate
- Siponomid
- Polatuzumab vedotin
- Solriamfetol hydrochloride
- Fostamatinib disodium hexahydrate
